TargetRx CEO Michael Luby to Drive Pharmaceutical Marketing & Sales Industry Discussion at June Conferences

HORSHAM, Pa.--(BUSINESS WIRE)--June 15, 2005--

To share expertise regarding how to increase effectiveness across sales and marketing at Eye for Pharma's Marketing ROI USA, June 15 and WBR Pharma Force 2005, June 21

TargetRx, a marketing information services company that assists pharmaceutical companies in effectively selling and marketing their products, announced today that CEO Michael Luby will be a presenter at two industry events this month--Eyeforpharma's 5th Annual Marketing Congress, Marketing ROI USA, on Wednesday, June 15 at the Hilton City Avenue Hotel, Philadelphia, PA and WBR Pharma Force 2005, at the Sheraton Inner Harbor Hotel, Baltimore, MD on Tuesday, June 21. At these conferences, Mr. Luby's presentation will be centered on innovative solutions that help pharmaceutical companies make the leap from marketing and sales quantity to quality.

Michael J. Luby is a co-founder of TargetRx, bringing more than 15 years of pharmaceutical marketing and sales experience from a variety of therapeutic areas to his role as President, CEO and Board Member of the Company. As the CEO since the Company's inception in 1999, Mr. Luby has succeeded in raising over $50 million in capital, expanding the TargetRx team to more than 100 employees, and securing clients in the majority of the top 30 pharmaceutical companies worldwide. Mr. Luby is also the lead author on TargetRx's patent-pending method of analyzing the effectiveness of marketing and sales strategies. Prior to starting TargetRx, Mr. Luby spent 10 years at Merck & Co., Inc., where he created and executed marketing strategies for both the specialty and mass markets. The concept for TargetRx was born from his dissatisfaction with the lack of insightful, predictive and actionable marketing information from external sources during his tenure at Merck.

TargetRx is the only company in the world that provides pharmaceutical companies with "attitudinal intelligence" - the "why" behind physician prescribing behavior. By tapping their highly accurate large-sample normative database of physician attitudes, which includes over 70 million physician insights across 32 therapeutic classes, TargetRx can provide their clients with the most powerful predictive insights needed to drive increased effectiveness across sales and marketing.

About TargetRx

TargetRx is a marketing information services company that delivers actionable insight to pharmaceutical companies to help them effectively sell and market their products -- improving the performance of their brands. TargetRx employs a unique database approach to capturing physician attitudes and translating the findings into highly actionable information for its clients. TargetRx has developed a highly predictive, large-sample normative database of physician attitudes that uncovers the "why" behind physician behavior. These insights provide companies with benchmarks for how a product is currently performing, rich diagnostics that identify immediate ways to improve, and powerful forecasts that accurately predict future performance. TargetRx works with the majority of the top 30 pharmaceutical companies in the U.S. For further information, visit www.targetrx.com.